TOKYO—U.S. drugmaker Pfizer Inc. said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment.
The application is based on global Phase II/III trials that Japan was part of, Pfizer said in a statement.
Pfizer Says It Applied for Japan Government’s Approval for Oral COVID-19 Drug
A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken on Sept. 29, 2021. Dado Ruvic/Reuters
|Updated:
